Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002030 · ClinicalTrials.gov registry record · NA
An Open Label Study to Evaluate the Long-Term Safety and Effectiveness of Aerosol Pentamidine in the Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients
A NA study, sponsored by Fisons.
- Completed
- Registry status
- NA
- Development phase
NCT00002030: Completed NA study, sponsored by Fisons.
NCT00002030 is a NA study that has completed, run by Fisons. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00002030, a NA study, has completed, sponsored by Fisons.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
To evaluate the safety, tolerability, and efficacy of long term, bi-weekly administration of aerosol pentamidine when used as a prophylactic agent in patients who have had at least two or more episodes of AIDS-associated Pneumocystis carinii pneumonia (PCP).
Interventions
- DRUG Pentamidine isethionate
Trial Details
| Field | Value |
|---|---|
| Phase | NA |
What the finished NCT00002030 record still lists
NCT00002030 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Pentamidine isethionate is the first listed.
NCT00002030 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00002030 about?
NCT00002030 is a clinical study titled "An Open Label Study to Evaluate the Long-Term Safety and Effectiveness of Aerosol Pentamidine in the Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients". To evaluate the safety, tolerability, and efficacy of long term, bi-weekly administration of aerosol pentamidine when used as a prophylactic agent in patients who have had at least two or more episodes of AIDS-associated Pneumocystis carinii pneumonia (PCP).
What is the current status of trial NCT00002030?
This trial is currently completed. It is a NA study.
What interventions are being tested in trial NCT00002030?
The interventions under investigation include: Pentamidine isethionate (DRUG).
Who is sponsoring clinical trial NCT00002030?
This trial is sponsored by Fisons, which has 5 total clinical trials registered on ClinicalTrials.gov.